GMAB

Genmab A/s -sp Adr

-$21.0M

Net Activity

Institutions Holding

273

Popularity Rank

#2186

Avg Weight

0.09%

Total Value

$2.2B

Ownership Trend

273 institutions currently hold GMAB, with 148 net buyers and 152 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

152

Net Buying Institutions

148

Key Holders

View all 273 holding institutions

Quarterly Activity

Recent Activity

+$1.0B

Total Buy Value

$1.6B

Total Sell Value

New buy40
Trim95
Add108
Sold out57

148

Net Buyers

152

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding GENMAB A/S -SP ADR (GMAB)?
Major stakeholders currently include Orbis Allan Gray Ltd ($346.8M), Alliancebernstein L.p. ($294.4M), Paradigm Biocapital Advisors LP ($213.8M). Based on the latest 13F filings, there are a total of 273 tracked investment funds and institutions maintaining positions in GMAB.
What is the overall institutional sentiment toward GMAB recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $21.0M, driven by 148 managers accumulating shares while 152 reduced their exposure.
Which institutions have been selling or reducing their GMAB positions?
In the latest period, 95 funds trimmed their holdings, and 57 managers completely exited their positions. The aggregate reported sell value was $1.6B.
Are there any notable investors adding GMAB to their portfolios?
Yes, buying activity remains notable. 40 institutions opened new positions in {ticker}, and 108 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.0B.

Related Stocks